Article
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.
Clinical genetics - 1 Dec 2017
Muller M, Ferlicot S, Guillaud-Bataille M, Le Teuff G, Genestie C, Deveaux S, Slama A, Poulalhon N, Escudier B, Albiges L, Soufir N, Avril M-F, Gardie B, Saldana C, Allory Y, Gimenez-Roqueplo A-P, Bressac-de Paillerets B, Richard S, Benusiglio P R
Abstract excerpt
We addressed uncertainties regarding hereditary leiomyomatosis and renal cell carcinoma (HLRCC) by exploring all French cases, representing the largest series to date. Fumarate hydratase (FH) germline testing was performed with Sanger sequencing and qPCR/MLPA. Enzyme activity was measured when necessary. We carried out whenever possible a pathology review of RCC and S-(2-succino)-cysteine (2SC)/fumarate hydratase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
